Pregnancy in patients with beta-thalassemia intermedia: outcome of mothers and newborns.
Little is known about the outcome of pregnancy in women with beta-thalassemia intermedia (TI). Over 10 years, maternal and neonatal outcomes of women with TI followed at a single thalassemia center were reviewed. Nine spontaneous pregnancies in five women with TI were studied. Six pregnancies resulted in live newborns; two were complicated by first-trimester abortions and one by an unexplained intrauterine fetal death at 36 weeks' gestation. Two patients had splenectomy before pregnancy: one required cesarean delivery and splenectomy at 31(2/7) weeks' gestation for worsening hemolytic anemia and thrombocytopenia and another had splenectomy 8 weeks postpartum for symptomatic hypersplenism. Two patients had received transfusions before pregnancy, and two required them for the first time during pregnancy and developed antibodies, which contributed to worsening of their anemia and repeated transfusions. The mean number of transfusions received during pregnancy was 8.0 +/- 5.2 units. The mean lowest hemoglobin level in pregnancy was 5.2 +/- 2.0 g/dl. Cesarean delivery was performed in 42.9% of cases. Mean gestational age at delivery was 36.7+/- 3.1 weeks with intrauterine growth restriction (IUGR) complicating 57.1% of cases. In conclusion, IUGR complicates more than half of pregnancies with TI. Transfusions are needed in most cases, even in non-transfusion-dependent patients. Postpartum splenectomy might be necessary in some patients.
Nassar
Anwar H
AH
Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon. an21@aub.edu.lb
Usta
Ihab M
IM
Rechdan
Johnny B
JB
Koussa
Suzanne
S
Inati
Adlette
A
Taher
Ali T
AT
D000022:Abortion, Spontaneous / Q000097:blood; D000743:Anemia, Hemolytic / Q000097:blood / Q000209:etiology / Q000628:therapy; D001323:Autoantibodies / Q000097:blood; D001803:Blood Transfusion; D002585:Cesarean Section; D005260:Female; D005313:Fetal Death / Q000097:blood; D005317:Fetal Growth Retardation / Q000097:blood; D005865:Gestational Age; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000628:therapy; D011256:Pregnancy Outcome; D013156:Splenectomy; D013921:Thrombocytopenia / Q000097:blood / Q000209:etiology / Q000628:therapy; D017086:beta-Thalassemia / Q000097:blood / Q000150:complications / Q000628:therapy
D001323:Autoantibodies